"Preclinical" AD revisited: neuropathology of cognitively normal older adults - PubMed (original) (raw)
. 2000 Aug 8;55(3):370-6.
doi: 10.1212/wnl.55.3.370.
Affiliations
- PMID: 10932270
- DOI: 10.1212/wnl.55.3.370
"Preclinical" AD revisited: neuropathology of cognitively normal older adults
F A Schmitt et al. Neurology. 2000.
Abstract
Objective: To classify neuropathologic alterations in the brains of nondemented older adults using current sets of criteria for AD.
Background: AD neuropathologic alterations are found in the brains of some nondemented elderly subjects and suggest the possibility of presymptomatic AD. Three sets of guidelines have been developed to classify AD using senile plaques, neuritic plaques, and neurofibrillary tangles (NFT).
Methods: Neuropathologic changes in 59 older adults followed longitudinally with a standard battery of mental status measures were investigated using Khachaturian, Consortium to Establish a Registry for Alzheimer's Disease (CERAD), and National Institute on Aging-Reagan Institute (NIA-RI) guidelines. AD neuropathologic markers were evaluated in neocortical and allocortical regions. Cases were categorized as neuropathologically "normal" or "AD-like" and compared for possible mental status differences.
Results: Between 11 and 49% of cases met one or more of the three classifications of AD. With adjustments for multiple comparisons, only NFT in hippocampal CA1 region were associated with autopsy age, suggesting that this may represent a pathologic process associated with normal brain aging. Using the NIA-RI guidelines, subjects in the AD-like group performed less well on the immediate paragraph recall and word-list delayed recall than their counterparts who did not meet these guidelines.
Conclusions: These data indicate that the prevalence of "preclinical" AD in our population is relatively low based on the NIA-RI classification. Although many subjects had AD-like changes based on CERAD and Khachaturian guidelines, they exhibited no differences in mental performance, suggesting that the aging brain may be able to withstand such structural changes without meaningful impact on mental functioning.
Similar articles
- Neuropathology of cognitively normal elderly.
Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE, Dickson DW, Johnson KA, Petersen LE, McDonald WC, Braak H, Petersen RC. Knopman DS, et al. J Neuropathol Exp Neurol. 2003 Nov;62(11):1087-95. doi: 10.1093/jnen/62.11.1087. J Neuropathol Exp Neurol. 2003. PMID: 14656067 - Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Newell KL, et al. J Neuropathol Exp Neurol. 1999 Nov;58(11):1147-55. doi: 10.1097/00005072-199911000-00004. J Neuropathol Exp Neurol. 1999. PMID: 10560657 - Alzheimer neuropathologic alterations in aged cognitively normal subjects.
Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Davis DG, et al. J Neuropathol Exp Neurol. 1999 Apr;58(4):376-88. doi: 10.1097/00005072-199904000-00008. J Neuropathol Exp Neurol. 1999. PMID: 10218633 - Neuropathology of Alzheimer's disease: a critical update.
Jellinger KA, Bancher C. Jellinger KA, et al. J Neural Transm Suppl. 1998;54:77-95. doi: 10.1007/978-3-7091-7508-8_8. J Neural Transm Suppl. 1998. PMID: 9850917 Review. - Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer's disease.
Jellinger KA, Bancher C. Jellinger KA, et al. Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S55-65. doi: 10.1016/s0197-4580(97)00071-7. Neurobiol Aging. 1997. PMID: 9330987 Review.
Cited by
- Integrative Single-Plaque Analysis Reveals Signature Aβ and Lipid Profiles in the Alzheimer's Brain.
Enzlein T, Lashley T, Sammour DA, Hopf C, Chávez-Gutiérrez L. Enzlein T, et al. Anal Chem. 2024 Jun 18;96(24):9799-9807. doi: 10.1021/acs.analchem.3c05557. Epub 2024 Jun 3. Anal Chem. 2024. PMID: 38830618 Free PMC article. - Biomarker-based staging of Alzheimer disease: rationale and clinical applications.
Therriault J, Schindler SE, Salvadó G, Pascoal TA, Benedet AL, Ashton NJ, Karikari TK, Apostolova L, Murray ME, Verberk I, Vogel JW, La Joie R, Gauthier S, Teunissen C, Rabinovici GD, Zetterberg H, Bateman RJ, Scheltens P, Blennow K, Sperling R, Hansson O, Jack CR Jr, Rosa-Neto P. Therriault J, et al. Nat Rev Neurol. 2024 Apr;20(4):232-244. doi: 10.1038/s41582-024-00942-2. Epub 2024 Mar 1. Nat Rev Neurol. 2024. PMID: 38429551 Review. - Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease.
Yu SP, Jiang MQ, Shim SS, Pourkhodadad S, Wei L. Yu SP, et al. Mol Neurodegener. 2023 Jul 3;18(1):43. doi: 10.1186/s13024-023-00636-1. Mol Neurodegener. 2023. PMID: 37400870 Free PMC article. Review. - Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease.
Mahady LJ, Perez SE, Malek-Ahmadi M, Mufson EJ. Mahady LJ, et al. J Comp Neurol. 2023 Dec;531(18):2080-2108. doi: 10.1002/cne.25466. Epub 2023 Mar 29. J Comp Neurol. 2023. PMID: 36989381 - The association of MIND diet with cognitive resilience to neuropathologies.
Wagner M, Agarwal P, Leurgans SE, Bennett DA, Schneider JA, Capuano AW, Grodstein F. Wagner M, et al. Alzheimers Dement. 2023 Aug;19(8):3644-3653. doi: 10.1002/alz.12982. Epub 2023 Feb 28. Alzheimers Dement. 2023. PMID: 36855023 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous